Disturbances of thyroid function tests by drugs

Acta Medica Austriaca

Volumn 23, Issue 1-2, 1996, Pages 57-60

  Wenzel, K W ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE   (Germany)

Author keywords

circulating hormone concentrations; drug interferences; in vitro tests; thyroid function; thyroid hormones; TRH test; TSH

Indexed keywords

AMIODARONE; ANDROGEN; ANTICONVULSIVE AGENT; ASPARAGINASE; BIPERIDEN; CARBAMAZEPINE; CHLORPROMAZINE; DIAMORPHINE; DOMPERIDONE; DOPAMINE; ESTROGEN; FENCLOFENAC; FENOPROFEN; FUROSEMIDE; GLUCOCORTICOID; HALOPERIDOL; HEPARIN; HORMONE; IODINE; LEVODOPA; METHADONE; METOCLOPRAMIDE; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENYLBUTAZONE; PHENYTOIN; PRIMIDONE; PROPRANOLOL; SALICYLIC ACID DERIVATIVE; SULPIRIDE; THYROXINE;

ENZYME INDUCTION; HUMAN; PROTEIN DEFECT; REVIEW; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST;

AMIODARONE; DIAGNOSIS, DIFFERENTIAL; HUMANS; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0029994274     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Wenzel KW: Pharmacological interference with in vitro tests of thyroid function. Metabolism 1981;30:717-732.
2. Tal F, Korányi L, Kovács Zs, Endróczi E: Short-term effect of morphine on the thyroid gland in male rats. Acta Endocrinol 1984;105:511-514.
3. Morley MB, Shafer RB, Elson MK, Slag MF, Raleigh MJ, Brammer GL, Yuwiler A, Hershman JM: Amphetamine-induced hyperthyroxinemia. Ann Intern Med 1980;93:707-709.
4. McConnell RJ: Abnormal thyroid function test results in patients taking salsalate. JAMA 1992;267:1242-1243.
5. Latham BB, Horst E, Nankin H, Lin T, Osterman J: Abnormal thyroid function tests in a patient and two normal volunteers treated with salsalate. Am J Med 1993;305:111-113.
6. Mendel AM, Frost PH, Kunitake ST, Cavalieri AR: Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. J Clin Endocrinol Metab 1987;65:1259-1264.
7. Davies PH, Franklyn JA: The effects of drugs on tests of thyroid function. Eur J Clin Pharmacol 1991;40:439-451.
8. Pearson DW, Ratcliffe WA, Thomson JA, Ratcliffe JG: Biochemical and clinical effects of fenclofenac in thyrotoxicosis. Clin Endocrinol 1982;16:369-373.
9. Capper SJ, Humphrey MJ, Kurtz AB: Inhibition of thyroxine binding to serum proteins by fenclofenac and related compounds. Clin Chim Acta 1981;112:77-83.
10. Tillman J, Leask TS, Campbell J, Logue FC, Fraser WD: Effect of fenoprofen on thyroid function tests. Clin Chim Acta 1986;161:233-238.
11. Lefort G, Latapie MJ, Ducassou D, Latapie JL: Fenoprofen and free triiodothyronine assays. Lancet 1986;IIi8506:577-578.
12. Stockigt JR, Lim C-F, Barlow JW, Stevens V, Topliss DJ, Wynne KN: High concentrations of furosemide inhibit serum binding of thyroxine. J Clin Endocrinol Metab 1984;59:62-66.
13. Newham HH, Hamblin PS, Long F, Lim C-F, Topliss DJ, Stockigt JR: Effect of oral frusemide on diagnostic indices of thyroid function. Clin Endocrinol 1987;26:423-431.
14. Surks MI, Ordene KW, Mann DN, Kumara-Siri MH: Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-releasing hormone in man and rat. J Clin Endocrinol Metab 1983;56:940-946.
15. Blackshear JL, Schultz AL, Napier JS, Stuart DD: Thyroxine replacement patients receiving phenytoin. Ann Intern Med 1983;99:341-342.
16. Isojarvi JIT, Pakarinen AJ, Myllylä VV: Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol 1989;46:1175-1178.
17. Connell JMC, Rapeport WG, Gordon S, Brodie MJ: Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazapine. Eur J Clin Pharmacol 1984;26:453-456.
18. Ohnhaus EE, Bürgi H, Burger A, Studer H: The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man. Eur J Clin Invest 1981;11:381-387.
19. Finke C, Juge C, Goumaz M, Kaiser C, Davies R, Burger AG: Effects of rifampicin on the peripheral turnover kinetics of thyroid homones in mice in men. J Endocrinol Invest 1987;10:157-162.
20. Eber O, Buchinger W, Lindner W, Lind P, Rath M, Klima G, Langsteger W, Költringer P: The effect of D- versus L-propranolol in the treatment of hyperthyroidism. Clin Endocrinol 1990;32:363-372.
21. Gamstedt A, Järnerot G, Kågedal B: Effect of betamethasone treatment on iodothyronines and thyroid hormone-binding proteins during controlled nutrition. Acta Endocrinol 1983;103:188-191.
22. Hershman JM, Nademanee K, Sugawara M, Pekary AE, Ross R, Singh BN, DiStefano JJ: Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone. Acta Endocrinol 1986;3:193-199.
23. Franklyn JA, Davis JR, Gammage MD, Littler WA, Ramsden DB, Sheppard MC: Amiodarone and thyroid hormone action. Clin Endocrinol 1985;22:257-264.
24. Safran M, Frang S-L, Bambini G, Pinchera A, Marino E, Braverman LE: Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotroph secretion in the rat. Am J Med Sci 1986;292:136-141.
25. Stäubli H, Studer H: Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis. Klin Wochenschr 1985;63:168-175.
26. Lambert M, Unger J, De Nayer P, Brohet C, Gangji D: Amiodarone-induced thyrotoxicosis suggestive of thyroid damage. J Endocrinol Invest 1990;13:527-530.
27. Nadamanee K, Piwonka RW, Singh BN, Hershman JM: Amiodarone and thyroid function. Prog Cardiovasc Dis 1989;31:427-437.
28. Albert SG, Alves LE, Rose EP: Thyroid dysfunction during chronic amiodarone therapy. J Am Coll Cardiol 1987;9:175-180.
29. Martino E, Aghini-Lombardi F, Bartalena L, Grasso L, Loviselli A, Velluzzi F, Pinchera A, Braverman LE: Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med 1994;154:2722-2726.
30. Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M, Aronin N, Macchia E, Haffajee C, Oduguardi L, Love J, Bigalli A, Baschieri L, Pinchera A, Braverman LE: Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984;101:28-32.
31. Balzano S, Sau F, Bartalena L, Ruscazio M, Balestrieri A, Cherchi A, Martino E: Diagnosis of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with severe nonthyroidal illness. J Endocrinol Invest 1987;10:589-591.
32. Heidemann PH, Stubbe P, Beck W: Transient secondary hypothyroidism and thyroxine binding globulin deficiency in leukemic children during polychemotherapy: An effect of L-asparaginase. Eur J Pediatr 1981;136:291-295.